GKB Ophthalmics Fair Value
GKB Ophthalmics (GKB) average fair value is ₹161.02 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹60.9 (+164.39%), fair value range ₹7.65–₹426.25.
Fair Value Analysis Export
GKB Fair Value vs Current Price — Valuation Summary
GKB average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Check GKB Ophthalmics market cap to track the company's total market size over time.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
GKB Fair Value Analysis — Data Sources & Coverage
GKB Ophthalmics financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit GKB Ophthalmics screener.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
GKB vs Healthcare Sector Peers — P/E, P/B & Market Cap
GKB Ophthalmics P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Jeena Sikho Lifecare | JSLL | 27.19 | 13.76 | ₹6,314 |
| Kerala Ayurveda | KERALAYUR | -7.9 | 18.27 | ₹225 |
| Sat Kartar Life | SATKARTAR | 11.08 | 2.77 | ₹191 |
| Sun Pharmaceutical | SUNPHARMA | 38.12 | 5.53 | ₹463,072 |
| Aurobindo Pharma | AUROPHARMA | 25.95 | 2.54 | ₹93,821 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.